Amylin Sues Lilly Over Byetta Sales Plans
Amylin Pharmaceuticals Inc. said Monday it had sued Eli Lilly & Co. in California, claiming Lilly's plans to use the same sales force to sell both Amylin's diabetes treatment and a...To view the full article, register now.
Already a subscriber? Click here to view full article